Clinical Trial: Opt-IVF for Personalized Medicine for Normal Responders

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07856082) titled 'Opt-IVF for Personalized Medicine for Normal Responders' on Sept. 28.

Brief Summary: A clinical trial will determine the effectiveness of the Opt-IVF decision-support tool in generating personalized, optimal drug-dosage profiles for each patient in the United States.

Study Start Date: Oct. 15

Study Type: INTERVENTIONAL

Condition: Ivf

Intervention: DEVICE: Opt-IVF

Opt-IVF predicted dosage for IVF

OTHER: control

Doctor prescribed dosage

Recruitment Status: RECRUITING

Sponsor: Urmila DIwekar

Information provided by (Responsible Party): Urmila DIwekar, Stochastic Research Technologies LLC

Disclaimer: Curated by HT Syndicatio...